Cidara Therapeutics, Inc. (16)

Browse by Contract Category

Contracts

Underwriting Agreement, dated October 7, 2021, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Common Stock) (Filed With SEC on October 8, 2021)
Form of Amended and Restated Employment Agreement by and between the Registrant and its executive officers (Filed With SEC on August 12, 2021)
Sixth Amendment to Lease by and between the Registrant and Nancy Ridge Technology Center, L.P., dated July 14, 2021 (Filed With SEC on August 12, 2021)
Description of the Registrant's Securities (Filed With SEC on August 13, 2020)
Collaboration and License Agreement, dated September 3, 2019, by and between the Registrant and Mundipharma Medical Company (Filed With SEC on November 8, 2019)
Underwriting Agreement, dated October 7, 2021, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Series X Convertible Preferred Stock) (Filed With SEC on October 8, 2021)
Fourth Amendment to Loan and Security Agreement by and between the Registrant and Pacific Western Bank, dated March 16, 2021 (Filed With SEC on May 13, 2021)
Third Amendment to Loan and Security Agreement, by and between the Registrant and Pacific Western Bank, dated November 5, 2019 (Filed With SEC on February 25, 2021)
Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan (Filed With SEC on December 7, 2020)
Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan (Filed With SEC on December 7, 2020)
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Cidara (Filed With SEC on December 7, 2020)
Description of the Registrant's Securities (Filed With SEC on March 4, 2020)
Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 4, 2020)
Investment Agreement, dated January 9, 2020, by and among the Company and the signatories thereto (Filed With SEC on January 10, 2020)
Stock Purchase Agreement, dated September 3, 2019, by and between the Registrant and Mundipharma AG (Filed With SEC on November 8, 2019)
Exchange Agreement, dated March 22, 2019, between the Company and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P. and... (Filed With SEC on March 22, 2019)